HPV can be serious for men, though most infections clear on their own without causing problems. About 45% of American men between 18 and 59 have a current genital HPV infection, and roughly 25% carry a high-risk type linked to cancer. The virus is so common that an estimated 75% of sexually active people will pick it up at some point. For the majority of men, HPV stays invisible and resolves quietly. For a smaller but significant number, it leads to genital warts or cancer.
Most Men Never Know They Have It
HPV in men is overwhelmingly silent. Most men who are exposed to the virus never develop visible symptoms, and even those infected with cancer-linked strains typically have no signs at all. The virus is described as “subclinical” in most male carriers, meaning it’s present but undetectable without specialized testing. This is actually more true for men than for women, partly because there’s no routine HPV screening test approved for men the way the Pap smear and HPV co-test exist for women.
That invisibility is a double-edged sword. On one hand, it means the infection probably won’t affect your health. On the other, it means you can carry and transmit HPV to partners without realizing it. Most sexually active couples share HPV back and forth until their immune systems suppress the infection.
Genital Warts: The Most Common Visible Problem
When HPV does cause symptoms in men, genital warts are by far the most likely outcome. These are caused by low-risk HPV types (mainly types 6 and 11), which are responsible for roughly 90% of all genital wart cases in both men and women. The warts can appear on the penis, scrotum, groin, or around the anus, and they range from small flat bumps to larger cauliflower-shaped growths.
Genital warts aren’t dangerous in the sense that they don’t become cancerous. But they can be persistent, uncomfortable, and stressful. Treatment options include topical medications and in-office removal, though warts can recur even after treatment because the underlying virus may still be present. The strains that cause warts are different from the strains that cause cancer, so having warts doesn’t mean you’re at higher risk for HPV-related cancers.
The Cancer Risk Is Real but Specific
This is where HPV gets genuinely concerning for men. High-risk HPV types, particularly types 16 and 18, can cause three types of cancer in men: throat cancer, anal cancer, and penile cancer. The numbers from CDC cancer registries covering 2018 to 2022 paint a clear picture of which matters most.
Throat cancer (specifically, oropharyngeal cancer affecting the base of the tongue and tonsils) is the big one. An estimated 13,600 cases per year in men are probably caused by HPV. That dwarfs both anal cancer (about 2,300 HPV-caused cases per year in men) and penile cancer (about 900 cases per year). In fact, HPV-related throat cancer in men is now more common than cervical cancer in women, which is a striking shift from decades past when HPV was thought of almost exclusively as a women’s health issue.
The lag time between infection and cancer is long, often decades. A man infected with HPV-16 in his twenties might not develop throat cancer until his fifties or sixties. There’s no routine screening test for HPV-related throat cancer, which means it’s typically caught when symptoms appear: a persistent sore throat, difficulty swallowing, ear pain on one side, or a lump in the neck.
How the Body Fights HPV
Your immune system clears most HPV infections within one to two years. The concern is the small fraction of infections that persist, because persistent high-risk HPV is what eventually drives cells toward cancer. Research tracking men over time found that persistent genital HPV-16 infections lasting six months or longer occurred at a rate of roughly 1.5 to 1.9 per 100 person-years, meaning they’re relatively uncommon in any given year but add up over a lifetime of exposure.
Once your body fights off a specific HPV type, it does build some immune memory. Studies following men who developed antibodies to HPV-16 found that 90% still had those antibodies four years later. However, the natural immune response after infection is weaker and less reliable than the protection generated by vaccination. Having cleared an infection doesn’t guarantee you won’t be reinfected with the same type, and it offers no protection against the dozens of other HPV strains.
Condoms Help but Don’t Fully Protect
HPV spreads through skin-to-skin contact, not just through fluids, which is why condoms reduce but don’t eliminate transmission. Still, consistent condom use makes a meaningful difference. Men who always used condoms had a 50% lower chance of testing positive for HPV compared to those who used them less frequently. Among men with more than one sexual partner, always using condoms was associated with a 60 to 77% lower risk of infection with cancer-causing HPV types.
The key word is “consistent.” Occasional condom use showed much less benefit. The protective effect comes from using them every time, which reduces cumulative skin-to-skin exposure over the course of a relationship or across multiple partners.
Vaccination Is the Strongest Protection
The HPV vaccine protects against the high-risk types that cause most HPV-related cancers (types 16 and 18) along with the types responsible for 90% of genital warts (types 6 and 11). The current vaccine covers nine HPV types total.
The CDC recommends HPV vaccination through age 26 for anyone who wasn’t vaccinated earlier. The vaccine works best when given before any exposure to the virus, which is why it’s routinely recommended starting at age 11 or 12, but it still provides benefit for men in their twenties who haven’t been exposed to all the covered types. For men and women between 27 and 45 who were never vaccinated, the decision is more individualized, since most people in that age range have already encountered the most common HPV types.
If you start the vaccine series at 15 or older, you’ll need three doses spread over six months. Starting before age 15 requires only two doses. The vaccine generates a much stronger and more durable immune response than natural infection, which is why it’s effective at preventing HPV-related cancers even though most people’s immune systems can eventually clear the virus on their own. Clearing an infection and preventing the cellular damage that leads to cancer decades later are two different things.
Why Men Should Pay Attention
HPV has historically been framed as a women’s health concern because of its link to cervical cancer. That framing is outdated. Men now account for the majority of HPV-related cancers in the United States, driven almost entirely by the surge in HPV-linked throat cancers. Unlike cervical cancer, which can be caught early through routine screening, there’s no equivalent early detection tool for the cancers HPV causes in men.
For most men, HPV will come and go without consequence. But the absence of symptoms doesn’t mean the absence of risk, especially over a lifetime. Vaccination before or during early sexual activity is the most effective way to reduce that risk. For men past the recommended vaccine age, consistent condom use and awareness of symptoms like persistent throat problems or unusual growths in the genital or anal area remain the practical tools available.